Qilian International Holding Group Ltd./$BGM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Qilian International Holding Group Ltd.
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
Ticker
$BGM
Sector
Primary listing
Employees
323
Headquarters
Website
BGM Metrics
BasicAdvanced
$1.8B
-
-$0.20
-
-
Price and volume
Market cap
$1.8B
52-week high
$17.17
52-week low
$7.61
Average daily volume
92K
Financial strength
Current ratio
3.392
Quick ratio
2.645
Interest coverage (TTM)
-0.88%
Profitability
EBITDA (TTM)
0.673
Gross margin (TTM)
16.39%
Net profit margin (TTM)
-5.75%
Operating margin (TTM)
-2.25%
Effective tax rate (TTM)
29.01%
Revenue per employee (TTM)
$80,000
Management effectiveness
Return on assets (TTM)
-0.68%
Return on equity (TTM)
-3.43%
Valuation
Price to revenue (TTM)
2.891
Price to book
1.7
Price to tangible book (TTM)
1.9
Price to free cash flow (TTM)
-21.42
Free cash flow yield (TTM)
-4.67%
Free cash flow per share (TTM)
-0.469
Growth
Revenue change (TTM)
-45.99%
Earnings per share change (TTM)
-81.48%
Bulls say / Bears say
BGM’s share price has surged 135.64% over the past six months, reflecting strong investor confidence in the company’s new strategic direction (Yahoo Finance).
On April 25, 2025, BGM finalized its US$95 million acquisition of YX Management Co Ltd, issuing 47.5 million shares for full control of RONS Technology and advancing its AI-driven intelligent platform (PR Newswire).
On May 2, 2025, BGM announced the US$41.7 million all-stock acquisition of HM Management to extend its AI agent development capabilities in insurance and enterprise applications (PR Newswire).
Revenue for the six months ended March 31, 2025, dropped 57% year-over-year to US$12.56 million, while EBITDA fell to a loss of US$(4.7) million from a US$0.8 million profit, showing a sharp decline in core profitability (SEC Form 6-K).
The acquisition of YX alone led to the issue of 47.5 million new shares (32.6% of BGM’s outstanding stock), adding to dilution risks from other recent all-stock deals for Wonder Dragon, HM Management, Xingdao Intelligent, and YD Network (PR Newswire).
Serious legal uncertainties remain under PRC law and due to BGM’s use of a VIE structure, which may weaken shareholder rights and expose the company to regulatory changes that could disrupt operations or potentially lead to delisting under U.S. rules (SEC 20-F).
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Qilian International Holding Group Ltd. stock?
Qilian International Holding Group Ltd. (BGM) has a market cap of $1.8B as of September 15, 2025.
What is the P/E ratio for Qilian International Holding Group Ltd. stock?
The price to earnings (P/E) ratio for Qilian International Holding Group Ltd. (BGM) stock is 0 as of September 15, 2025.
Does Qilian International Holding Group Ltd. stock pay dividends?
No, Qilian International Holding Group Ltd. (BGM) stock does not pay dividends to its shareholders as of September 15, 2025.
When is the next Qilian International Holding Group Ltd. dividend payment date?
Qilian International Holding Group Ltd. (BGM) stock does not pay dividends to its shareholders.
What is the beta indicator for Qilian International Holding Group Ltd.?
Qilian International Holding Group Ltd. (BGM) does not currently have a Beta indicator.